Journal for ImmunoTherapy of Cancer (Nov 2023)

1403-A PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumor immunity

  • Wei Qiu,
  • Qi Sun,
  • Yi Yang,
  • Chirag Patel,
  • Meng Sun,
  • Yue Liu,
  • Kyle Halliwill,
  • Sarah Kim,
  • Rebecca Mathew,
  • Jennifer M Frost,
  • Jennifer A Roth,
  • Domenick Kennedy,
  • Robert T Manguso,
  • Kathleen B Yates,
  • Hakimeh Ebrahimi-Nik,
  • Christina K Baumgartner,
  • Arvin Iracheta-Vellve,
  • Keith M Hamel,
  • Kira Olander,
  • Thomas GR Davis,
  • Kathleen A McGuire,
  • Geoff T Halvorsen,
  • Omar I Avila,
  • Ashwin V Kammula,
  • Audrey J Muscato,
  • Prasanthi Geda,
  • Kelly Klinge,
  • Zhaoming Xiong,
  • Ryan Duggan,
  • Liang Mu,
  • Mitchell D Yeary,
  • James C Patti,
  • Tyler M Balon,
  • Carey Backus,
  • Angeline Chen,
  • Kenton Longenecker,
  • Joseph Klahn,
  • Cara Hrusch,
  • Navasona Krishnan,
  • Charles W Hutchins,
  • Jacqueline Aguado,
  • Marinka Bulic,
  • Payal Tiwari,
  • Kayla J Colvin,
  • Cun Lan Chuong,
  • Ian C Kohnle,
  • Matthew G Rees,
  • Andrew Boghossian,
  • Melissa Ronan,
  • Meng-Ju Wu,
  • Debattama R Sen,
  • Gabriel K Griffin,
  • Nabeel El-Bardeesy,
  • Patricia Trusk,
  • Joshua H Decker,
  • Stacey Fossey,
  • Marcia N Paddock,
  • Elliot P Farney,
  • Clay Beauregard,
  • Philip R Kym

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1403-A
Journal volume & issue
Vol. 11, no. Suppl 2

Abstract

Read online

No abstracts available.